home / stock / sngx / sngx news


SNGX News and Press, Soligenix Inc. From 09/03/20

Stock Information

Company Name: Soligenix Inc.
Stock Symbol: SNGX
Market: NASDAQ
Website: soligenix.com

Menu

SNGX SNGX Quote SNGX Short SNGX News SNGX Articles SNGX Message Board
Get SNGX Alerts

News, Short Squeeze, Breakout and More Instantly...

SNGX - NVAX, WLL among premarket gainers

Kensington Capital Acquisition (KCAC) +39%  as QuantumScape goes public via Kensington Capital merger. More news on: FibroGen, Inc., Fulgent Genetics, Inc., Soligenix, Inc., Stocks on the move, , Read more ...

SNGX - Soligenix Announces Investor Webcast Event: Advantages of the CiVax(TM) Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine

PRINCETON, N.J. , Sept. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it wi...

SNGX - LD Micro - 360 Companies Set to Present - this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

SNGX - Soligenix to Present at the LD Micro Conference

PRINCETON, N.J. , Aug. 27, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ...

SNGX - Soligenix EPS beats by $0.04, misses on revenue

Soligenix (NASDAQ: SNGX ) : Q2 GAAP EPS of -$0.10 beats by $0.04 . Revenue of $0.5M (-64.3% Y/Y) misses by $0.6M . Shares +0.5% PM. Press Release More news on: Soligenix, Inc., Earnings news and commentary, Healthcare stocks news, ,

SNGX - Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results

PRINCETON, N.J. , Aug. 14, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent...

SNGX - STX, BCS among premarket losers

Boxlight (NASDAQ: BOXL )   -27%  after  pricing  equity offering. More news on: Boxlight Corporation, Global Eagle Entertainment Inc., Sypris Solutions, Inc., Stocks on the move, , Read more ...

SNGX - Soligenix: Multiple Shots On Goal, Strong Evidence Of Success, And Attractive Valuation

With two Phase 3 assets approaching clinical trial readouts, a government-funded vaccine program including a potential COVID-19 play, and a valuation of approximately $70 million, Soligenix ( SNGX ) provides a compelling opportunity for investors. Unearthing hidden gems in the biopharma sector...

SNGX - TCOM, PII among premarket gainers

Eastman Kodak (NYSE: KODK ) +190% . More news on: Eastman Kodak Company, Spectrum Pharmaceuticals, Inc., Soligenix, Inc., Stocks on the move, , Read more ...

SNGX - Soligenix rallies on encouraging data on COVID-19 vaccine

Nano cap Soligenix (NASDAQ: SNGX ) jumps  46%  premarket on increased volume in reaction to the publication of preclinical data on CiVax, its heat-stable subunit COVID-19 vaccine candidate. More news on: Soligenix, Inc., Healthcare stocks news, Stocks on the move, Read mo...

Previous 10 Next 10